Amylyx
Amylyx is a Massachusetts-based pharmaceutical company that develops and commercializes novel therapeutics for the treatment of neurodegenerative diseases.
Business Model:
Revenue: $1.4M
Employees: 201-500
Industries / Tags:
Detailed Amylyx Information
Geographic Data
Address: 43 Thorndike Street
City: Cambridge
State: MA
Zip: 02141
Country: US
Financial Info
Stage:
series c
Raised Last:
$135M
Raised Total:$202M
Social
Metrics
2,620,710Website Global Rank
6,740Website Monthly Traffic
Twitter Followers
Description
Amylyx is a Massachusetts-based pharmaceutical company that develops and commercializes novel therapeutics for the treatment of neurodegenerative diseases.
Contact Phone:
+16176830917
Contact Email:
Amylyx went public on 1/7/2022 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
1/7/2022
IPO Valuation:
$1B
Ticker Symbol:
AMLX
IPO Price:
$19/share
Amount Raised:
$190M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
